Healthpeak Properties, Inc.
Healthpeak Properties, Inc. Q2 FY26 Results — Earnings Call Analysis
Q2 FY26 earnings call: what management said on revenue, margins and capex.
What the Q2 FY26 call signalled
3 of 4 strong
The short version
- Life Science Occupancy Growth: Expect total life science occupancy to increase by at least 100 basis points by year-end 2026, driven by a robust leasing pipeline and continuing net absorption. - Outpatient Medical: Continued strong leasing activity with 5-6% re-leasing spreads, 3% rent escalators, very modest leasing costs; supporting stable earnings growth.
From Healthpeak Properties, Inc.'s Q2 FY26 earnings-call transcript · updated 29 May 2026.
Revenue & Sales Performance
- Life Science Occupancy Growth: Expect total life science occupancy to increase by at least 100 basis points by year-end 2026, driven by a robust leasing pipeline and continuing net absorption.
- Outpatient Medical: Solid execution with consistent 5-6% cash re-leasing spreads on renewals and 3% escalators; occupancy and leasing pipelines remain strong supporting steady revenue growth.
- Senior Housing: Phenomenal 1Q results with expected accretion from Janus Living IPO in 2027 and beyond; strong revenue and EBITDA growth reported.
- Leasing Activity: Significant leasing activity post-1Q with 318,000 sq ft leases executed since April and 700,000 sq ft under LOI, indicating robust demand and revenue potential.
2 more points from Healthpeak Properties, Inc.'s call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Healthpeak Properties, Inc. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- $1 billion of capital invested in the past 12 months, including $714 million in senior housing acquisitions.
- Progress toward the $1 billion capital recycling target with $270 million proceeds already received.
- Gateway acquisition (late December/early January) is performing well, with upside expected in 2027 and beyond.
- $650 million of senior notes maturing in June to be refinanced, impacting second half 2026.
- $400 million senior unsecured delayed draw term loan secured, undrawn, available through December 2026.
- Focus on disciplined capital allocation, prioritizing core markets with high thresholds for new investments.
- No current intention for additional life science portfolio dispositions; capital mainly deployed into leasing, development, and acquisitions.
2 more points from Healthpeak Properties, Inc.'s call on capex
Create a free account to keep reading this call
Fundraising & Capital Structure
See what Healthpeak Properties, Inc. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The life science segment has a strong and broad-based leasing pipeline, including venture-backed biotech to large-cap pharma tenants.
- Approximately 700,000 square feet of leases are under Letter of Intent (LOI).
- In the lab portfolio, approximately 355,000 square feet is under LOI, with about 80% new leasing and 75% on currently vacant space.
- There is robust leasing activity, including several deals greater than 50,000 square feet.
- There is significant new leasing pipeline in both outpatient and life science businesses, driving expectations for occupancy growth through year-end.
2 more points from Healthpeak Properties, Inc.'s call on order book
Create a free account to keep reading this call
Continue your research
Others in Health Care REITs this season
- Omega Healthcare Investors, Inc. (Q2 FY26)
Omega Healthcare Investors, Inc. Q2 FY26 quarterly results analysis. Skilled nursing facilities (SNFs) expected to grow at a high single-digit to low double-dig
- Ventas, Inc. (Q2 FY26)
Ventas, Inc. Q2 FY26 quarterly results analysis. Ventas expects continued strong growth in senior housing, with SHOP same-store NOI growth projected at 16% midp
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Healthpeak Properties, Inc. and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Healthpeak Properties, Inc. Q2 FY26 results?
- Life Science Occupancy Growth: Expect total life science occupancy to increase by at least 100 basis points by year-end 2026, driven by a robust leasing pipeline and continuing net absorption. - Outpatient Medical: Continued strong leasing activity with 5-6% re-leasing spreads, 3% rent escalators, very modest leasing costs; supporting stable earnings growth.
What is Healthpeak Properties, Inc. share price analysis?
Healthpeak Properties, Inc. currently shows a below-average growth signal. The stock trades at a P/E of 62.6 with a market cap of $13,451. Investors should review the full earnings analysis for detailed insights.
Is Healthpeak Properties, Inc. planning capital expenditure?
- $1 billion of capital invested in the past 12 months, including $714 million in senior housing acquisitions.
Keep Healthpeak Properties, Inc. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.